P453: CDK6 DEGRADATION IS IMPEDED BY P16INK4A AND P18INK4C IN AML

• B. Schmalzbauer,
• T. Thondanpallil,
• G. Heller,
• C.-M. Sperl,
• I. M. Mayer,
• V. M. Knab,
• S. Nebenfuehr,
• M. Zojer,
• A. C. Mueller,
• F. Fontaine,
• T. Klampfl,
• V. Sexl,
• K. Kollmann

Affiliations

B. Schmalzbauer

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

T. Thondanpallil

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

G. Heller

2 Department of Medicine I, Division of Oncology, Medical University of Vienna

C.-M. Sperl

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

I. M. Mayer

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

V. M. Knab

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

S. Nebenfuehr

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

M. Zojer

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

A. C. Mueller

3 CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

F. Fontaine

3 CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

T. Klampfl

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

V. Sexl

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna

K. Kollmann

1 Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna